Mannose ameliorates experimental colitis by protecting intestinal barrier integrity
Citations Over TimeTop 1% of 2022 papers
Abstract
Metabolite alteration has been associated with the pathogenesis of inflammatory bowel disease (IBD), including colitis. Mannose, a natural bioactive monosaccharide that is involved in metabolism and synthesis of glycoproteins, exhibits anti-inflammatory and anti-oxidative activities. We show here that the circulating level of mannose is increased in patients with IBD and mice with experimental colitis. Mannose treatment attenuates intestinal barrier damage in two mouse colitis models, dextran sodium sulfate (DSS)-induced colitis and spontaneous colitis in IL-10-deficient mice. We demonstrate that mannose treatment enhanced lysosomal integrity and limited the release of cathepsin B, preventing mitochondrial dysfunction and myosin light chain kinase (MLCK)-induced tight junction disruption in the context of intestinal epithelial damage. Mannose exerts a synergistic therapeutic effect with mesalamine on mouse colitis. Cumulatively, the results indicate that mannose supplementation may be an optional approach to the treatment of colitis and other diseases associated with intestinal barrier dysfunction.
Related Papers
- → Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts.(1996)148 cited
- → Evidence for the presence of two distinct phosphoenolpyruvate: Mannose phosphotransferase systems inStreptococcus mutansGS5-2(1987)6 cited
- → FORMATION OF α‐1,2‐ AND α‐1,3‐LINKED MANNOSE DISACCHARIDES FROM MANNOSYL RETINYL PHOSPHATE BY RAT LIVER MEMBRANE ENZYMES*,†(1981)10 cited
- → Human fibroblasts prefer mannose over glucose as a source of mannose for N-glycosylation. Evidence for the functional importance of transported mannose.(1997)4 cited
- → Formation of α-1,2- and α-1,3-linked mannose disaccharides from dolichyl mannosyl phosphate by rat liver membrane enzymes(1981)